Letter from the NABP endorsing the Federation's Model Guidelines
Endorsed: March 26, 2001

David E. Joranson
Senior Scientist, Director
Pain & Policy Studies Group
World Health Organization Collaborating Center
for Policy and Communications
University of Wisconsin Comprehensive Cancer Center
1900 University Avenue
Madison, WI 53705

At its recent meeting, the NABP Executive Committee reviewed the Model Guidelines for the Use of Controlled Substances for Treatment of Pain and adopted by the Federation of State Medical Boards. The Executive Committee endorsed the guidelines as a document that the state boards of pharmacy would find useful in their regulation of pain management therapies and medications.

By copy of this letter, we are forwarding this information to the state boards of pharmacy.

If I can be of further assistance, please feel free to contact me.

Cordially,

Carmen Catizone, MS, Rph

Executive Director/Secretary

CC/ss

NABP Executive Committee

Executive Officers-State Boards of Pharmacy